Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Once-weekly semaglutide in adolescents with obesity In a comprehensive study involving 201 adolescents, most of whom were battling obesity, the effectiveness of semaglutide was put to the test
Minimally invasive, safe, and requires no downtime
For example, a meta-analysis of ten trials with nearly 7,000 participants showed that GI problems affected 39%, 46%, and 49% of participants receiving the 5mg, 10mg, and 15mg doses, respectively [34]
The evidence-based starting dose is 0.25mg subcutaneously daily for 3 days, escalating to 0.5mg daily for 710 days during the loading phase
US$ 23.61
US$ 22.27
US$ 26.37
